Novo Nordisk Collaborates With Life Edit Therapeutics
Novo Nordisk And Life Edit Therapeutics Announced A Research And Development Collaboration To Discover And Develop Gene Editing Therapies Against A Select Set Of Therapeutic Targets.Under The Agreement, Life Edit Will Receive An Upfront Cash Payment And Is Eligible To Receive Potential Development, Regulatory, And Commercial Milestones Of 335 Million Us Dollars For Each Of The First Two Development Programmes Under The Collaboration And Up To 250 Million Dollars For Each Of The Following Five Development Programmes Under The Collaboration. The Collaboration Between The Two Companies Allows For Development Of Up To Seven Programmes. Moreover, This Opportunity Will Co-Create Novel Treatments For Multiple Genetic Diseases Based On Life Edit
Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!
